We’ll also address what you can do to ease your symptoms and learn to recognize signs that it may be time ... disappear shortly after delivery. Nasal polyps are benign (noncancerous) growths ...

Lazard acted as the exclusive financial advisor to Paratek Pharmaceuticals, and Skadden, Arps, Slate, Meagher & Flom LLP served as its legal advisor. Evercore acted as the exclusive financial advisor ...

Insmed Incorporated , a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, presented 11 ...

If the soreness is accompanied by other symptoms such as a high fever, significant swelling, or pain that gets increasingly worse, it may be the sign of a serious issue ... more mucus than normal ...

GSK's Nucala wins FDA nod for COPD with eosinophilic phenotype, marking its fifth indication and strengthening its respiratory portfolio.

To understand the mechanism of the nasal vaccines, the researchers first injected mice with a traditional mRNA COVID-19 shot, directly into the muscle. Later, they gave the mice a booster vaccine ...

Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

Labelling warns that certain nasal conditions, such as nasal polyps or a history of nasal surgery, may affect the absorption of the new drug. ARS said it will launch the product onto the market ...

President Donald Trump signed the Take It Down Act on Monday, a bipartisan law that enacts stricter penalties for distributing nonconsensual explicit images, including deepfakes and revenge porn.

US President Donald Trump has signed a bill criminalizing nonconsensual artificial intelligence-generated deepfake porn, which also requires websites to take down any illicit images within 48 hours.

THEY promise to give you a glowing, bronze complexion, but the new trend of nasal tanning sprays is packed with risks. So much so, former Miss GB Jen Atkins has issued a stark warning after using ...

Simultaneously, the three regulators are also reviewing a second potential indication for depemokimab as an add-on therapy for chronic rhinosinusitis with nasal polyps (CRSwNP). GSK has said ...